BLUE: יחס מחיר לרווח לקצב צמיחה bluebird bio, Inc
High margins and pricing power of the gene therapy pioneer bluebird bio, Inc. (BLUE) support growth, which is why a PEG ratio chart is available in the GURU.Markets system, where this metric equals 0.00. However, the commercialization of anemia treatments and the transition to robotic bioreactors to eliminate defects create certain operational risks, impacting the current market value of the assets.
bluebird bio, Inc. (BLUE) - פילוחי מדדים ודוחות פיננסיים
The stability of bluebird bio, Inc. (BLUE) depends on international patent protection and the uninterrupted import of biocomponents amid geopolitical pressure. The PEG ratio compares the business's market value with its earnings growth rate, allowing investors to identify an undervalued asset when the value is below one, which is clearly reflected in the price action of this chart.
